Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Arterra Bioscience SpA ( (IT:ARBS) ) is now available.
Arterra Bioscience S.p.A. has sold its entire stake in Longevity Bioscience S.r.l. to Exosomics S.p.A. for Euro 43,999.17. This strategic move may impact Arterra’s operations by allowing it to focus more on its core biotechnology innovations and collaborations, potentially enhancing its market positioning in the biotech industry.
More about Arterra Bioscience SpA
Arterra Bioscience S.p.A. is an Italian green biotech company specializing in research and development in biotechnology. Listed on the Euronext Growth Milan market since 2019, Arterra focuses on developing products and processes using living organisms for applications in cosmetics, agriculture, and nutraceuticals. Founded in 2004 by Gabriella Colucci, the company is headquartered in Naples and has established collaborations with various companies and research institutes globally.
Average Trading Volume: 14,714
Technical Sentiment Signal: Buy
Current Market Cap: €16.78M
See more insights into ARBS stock on TipRanks’ Stock Analysis page.